ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)
Status:
Completed
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
Diabetic and nondiabetic patients will be evaluated if they had a first diagnosis of
non-valvular atrial fibrillation and in therapy with non-vitamin K oral anticoagulants and
with vitamin K oral anticoagulants.